A Phase I Study to Evaluate the Safety of the the Recombinant Norovirus Hexavalent Vaccine in Healthy Subjects
Condition: Gastroenteritis Interventions: Biological: Recombinant Norovirus Hexavalent Vaccine; Other: Matching Placebo Sponsors: Syneos Health; Chengdu Kanghua Biological products Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2023 Category: Research Source Type: clinical trials
The Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu Virus
Conditions: Bacterial Growth; Novel Influenza A (H1N1) Intervention: Device: A novel electrolyzed water spray reduces numbers of bacteria E-coli and an attenuated human flu virus on human hands Sponsors: Dove Medical Press Ltd; The Affiliated Hospital of Qingdao University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials
